WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

Oct 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-10-17

Reporting Person: ZENNER PATRICK J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-17	Common Stock	P	335.00	$93.9367	Acquired	66474.878	Direct
2017-11-10	Common Stock	S	335.00	$101.5426	Disposed	66139.878	Direct
2018-07-31	Common Stock	P	57.00	$110.5529	Acquired	66196.878	Direct
2019-02-28	Common Stock	P	54.00	$105.1371	Acquired	66250.878	Direct
2019-03-19	Common Stock	S	11.00	$106.0163	Disposed	66239.878	Direct
2019-03-21	Common Stock	S	33.00	$106.4856	Disposed	66206.878	Direct
2019-07-18	Common Stock	S	20.00	$121.8342	Disposed	66186.878	Direct
2019-07-25	Common Stock	S	47.00	$132.2151	Disposed	66139.878	Direct

Footnotes

F1: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a managed investment strategy involving the securities of multiple issuers. These managed accounts are held in a trust for which the reporting person is a trustee and/or beneficiary. The reporting person was unaware of the transactions at the time they occurred and did not exercise any investment control over the purchases and sales. The reporting person has disgorged to the issuer all profits related to these purchases and sales.